Performance Evaluation of the Agilent 1290 Infinity II High Speed Pump using Phosphate Buffer as Mobile Phase
Technical notes | 2016 | Agilent TechnologiesInstrumentation
The adjustment of mobile phase pH using phosphate buffers is crucial in reversed-phase HPLC to ensure optimal retention of ionizable compounds and prevent column damage. Consistent mobile phase composition and pump performance are essential for high reproducibility and longevity of HPLC systems.
This overview evaluates the Agilent 1290 Infinity II High Speed Pump performance when using a 25 mM phosphate buffer (pH 3.0) and acetonitrile in an antibacterial drug separation. The study assesses retention time precision, resolution, peak symmetry across 90 consecutive injections, and evaluates potential system pressure changes.
The analysis employed the following conditions:
Retention time reproducibility was exceptional, with relative standard deviations below 0.05 % for most analytes over six runs and under 0.07 % over 90 runs. Resolutions remained high (e.g., >75 between key components), and peak symmetry stayed near unity. System backpressure increased by only 18 bar over 90 injections (0.02 % per run), indicating minimal column fouling.
The demonstrated robustness enables reliable analysis of ionizable and pH-sensitive compounds in pharmaceutical quality control, reducing downtime and maintenance costs. High throughput laboratories can leverage this performance for complex separations requiring buffer-based mobile phases.
Advancements in pump materials and seal technologies may further improve buffer compatibility and long-term stability. Integration with automated sample preparation and real-time monitoring by advanced detectors could expand applications to proteomics and small‐molecule drug discovery workflows.
The Agilent 1290 Infinity II High Speed Pump maintains exceptional performance with phosphate buffer mobile phases, delivering outstanding retention precision, resolution, and system integrity even over extended sequences. This capability supports rigorous analytical demands in pharmaceutical and research laboratories.
HPLC
IndustriesClinical Research
ManufacturerAgilent Technologies
Summary
Significance of the Topic
The adjustment of mobile phase pH using phosphate buffers is crucial in reversed-phase HPLC to ensure optimal retention of ionizable compounds and prevent column damage. Consistent mobile phase composition and pump performance are essential for high reproducibility and longevity of HPLC systems.
Study Aims and Overview
This overview evaluates the Agilent 1290 Infinity II High Speed Pump performance when using a 25 mM phosphate buffer (pH 3.0) and acetonitrile in an antibacterial drug separation. The study assesses retention time precision, resolution, peak symmetry across 90 consecutive injections, and evaluates potential system pressure changes.
Methodology and Instrumentation
The analysis employed the following conditions:
- Column: ZORBAX Eclipse Plus C18, 3.0×100 mm, 1.8 µm.
- Mobile phase A: 25 mM KH2PO4, pH 3.0; B: acetonitrile.
- Gradient flow: 1.6 mL/min, 5 % B initial to 80 % B over 11 min, 15 min total runtime.
- Injection volume: 3 µL; sample temp: 8 °C; column temp: 40 °C.
- Detection: PDA at 204 nm (ref 360 nm).
Used Instrumentation
- Agilent 1290 Infinity II High Speed Pump (G7120A).
- Agilent 1290 Infinity II Multisampler with cooler (G7167B).
- Agilent 1290 Infinity II Multicolumn Thermostat (G7116B).
- Agilent 1290 Infinity II Diode Array Detector with Max-Light cell (G7117B).
- Data system: Agilent OpenLAB CDS ChemStation.
Main Results and Discussion
Retention time reproducibility was exceptional, with relative standard deviations below 0.05 % for most analytes over six runs and under 0.07 % over 90 runs. Resolutions remained high (e.g., >75 between key components), and peak symmetry stayed near unity. System backpressure increased by only 18 bar over 90 injections (0.02 % per run), indicating minimal column fouling.
Practical Benefits and Applications
The demonstrated robustness enables reliable analysis of ionizable and pH-sensitive compounds in pharmaceutical quality control, reducing downtime and maintenance costs. High throughput laboratories can leverage this performance for complex separations requiring buffer-based mobile phases.
Future Trends and Opportunities
Advancements in pump materials and seal technologies may further improve buffer compatibility and long-term stability. Integration with automated sample preparation and real-time monitoring by advanced detectors could expand applications to proteomics and small‐molecule drug discovery workflows.
Conclusion
The Agilent 1290 Infinity II High Speed Pump maintains exceptional performance with phosphate buffer mobile phases, delivering outstanding retention precision, resolution, and system integrity even over extended sequences. This capability supports rigorous analytical demands in pharmaceutical and research laboratories.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Method Transfer from an Agilent 1100 Series LC to an Agilent 1260 Infinity II LC
2020|Agilent Technologies|Applications
Method Transfer from an Agilent 1100 Series LC to an Agilent 1260 Infinity II LC Proof of Equivalency for the Analysis of Antibacterial Drugs with Penicillin-like Structures Application Note Small Molecule Pharmaceuticals Author Abstract Sonja Krieger Instrument-to-instrument method transfer is…
Key words
penicillin, penicillinantibacterial, antibacterialamoxicillin, amoxicillinampicillin, ampicillindrugs, drugsinfinitylab, infinitylabtime, timearea, areastructures, structuresconventional, conventionalhplc, hplcmau, mauanalysis, analysismin, minretention
Analysis of Four β-Lactam Antibiotics in Water Using an Agilent 1290 Infinity II LC and an Agilent 6470 Triple Quadrupole LC/MS with Direct Injection and Online SPE
2017|Agilent Technologies|Applications
Analysis of Four β-Lactam Antibiotics in Water Using an Agilent 1290 Infinity II LC and an Agilent 6470 Triple Quadrupole LC/MS with Direct Injection and Online SPE Application Note Authors Abstract Alexander Timm, Rafael Peschke, and β-lactam antibiotics are some…
Key words
lactam, lactamspe, speantibiotics, antibioticsonline, onlinepiperacillin, piperacillinamoxicillin, amoxicillindirect, directpenicillin, penicillinampicillin, ampicillinwater, waterinjection, injectionloading, loadingvalve, valvedelay, delayuhplc
New Paradigm for HPLC Method Development
2000|Merck|Technical notes
VOL 18.1 TheReporter www.sigma-aldrich.com/TheReporter New Paradigm for HPLC Method Development Column: Mobile Phase: Discovery, 5cm x 4.6mm ID, 5µm particles A: O.1% HCO2H (pH 2.5) B: MeCN 0 - 4% in 0.8 min., 4 - 30% in 1.7 min. 3mL/min…
Key words
mecn, mecnpenicillin, penicillincyano, cyanolabpro, labprobonded, bondedantibiotics, antibioticsrheodyne, rheodynepseudoephedrine, pseudoephedrinepercent, percentdiscovery, discoveryacetaminophen, acetaminophenmau, mauphases, phaseslactam, lactamampicillin
High-Performance Biopharma Analysis - Application compendium
2021|Agilent Technologies|Guides
Agilent InfinityLab Bio LC Solutions High-Performance Biopharma Analysis Application compendium 2 Overcome Analytical Challenges in Biopharma The growing complexity of biopharma analysis calls for innovation that delivers excellence across the biopharmaceutical workflow. The Agilent InfinityLab Bio LC Solutions comprise a…
Key words
retention, retentionmin, minbio, biogradient, gradienttime, timenistmab, nistmabresponse, responsemau, maupeptide, peptidemapping, mappingagilent, agilentcharge, chargemab, mabrsd, rsdantibody